Company ' s Update on its Activity in Research and Development and FDA interactions On February 26, 2024, the Company announced the latest findings from the Company's pharmacokinetic study of its ...

Dr. Stephen Byrn, CSO of Improved Pharma remarked about the importance of this research. "Lauren's prior research experience with SLNs is critical for our success. As the industry moves forward ...

By Adria Calatayud Roche Holding said Johannes Clevers, head of pharmaceutical research and early development, will retire from the company after three years in the role. Clevers, who was also ...

Another world leader in pharma and biotechnology has partnered with GenerativeX to extend its reach with front-line physicians. Generative AI analyzes relevant data from research articles ...

While AI and innovation are generating increasing spillover effects in the global pharmaceutical industry and improving ...

About FSD Pharma FSD Pharma Inc. is a biotechnology company with three drug candidates in different stages of development. FSD BioSciences, Inc., a wholly owned subsidiary, is focused on ...

Press Contact: Sawa Himeno Head of Communications Dept., Rigaku Holdings Corporation [email protected] +81 90 6331 9843 Ayako Tsuboi Marketing Communications, Sales Dept., SPERA PHARMA, Inc ...

Team growth and development: This year Pharma Targeting saw a significant increase in headcount and staff promotions, with their global workforce nearly tripling. They are now just shy of 40 ...

ORLANDO, Fla., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ: NTRB) (NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced that it received the Certificate ...